MedEdge MEA

BD Receives FDA Clearance for Fingertip Blood Collection Device MedEdge MEA

Franklin Lakes, NJ – BD (Becton, Dickinson, and Company), a prominent global medical technology company, has secured 510(k) clearances from the U.S. Federal Drug Administ...

Read More
Is Your Healthcare Hub-and-Spoke System Broken? MedEdge MEA

Understanding the Impact on Revenue, Efficiency, and Patient Satisfaction. In healthcare, the hub-and-spoke model has emerged both as a strategic solution and a challe...

Read More
Olympus Achieves Science-Based Targets Certification for Net-Zero Emissions by 2040 MedEdge MEA

Tokyo- Olympus Corporation, a global MedTech leader, has received verification from the Science Based Targets initiative (SBTi) for its ambitious net-zero greenhouse gas...

Read More
Pfizer’s Promising Oral Treatment for Obesity Shows Positive Phase 2b Results MedEdge MEA

New York- Pfizer Inc. has announced promising topline data from its Phase 2b clinical trial (NCT04707313) evaluating the oral Glucagon-like peptide-1 receptor agonist (GL...

Read More
FDA Approves Eli Lilly’s Zepbound™ for Obesity Treatment MedEdge MEA

INDIANAPOLIS: Eli Lilly and Company’s (NYSE: LLY) innovative obesity treatment, Zepbound™ (tirzepatide) injection, has received the green light from the U.S. Food and Dru...

Read More
UN Progress Report Highlights Efforts to Improve Lives of Older People MedEdge MEA

The World Health Organization (WHO) and UN partners have released the first progress report for the UN Decade of Healthy Ageing. The report highlights efforts to improve...

Read More
GE HealthCare Announces New Data Validating Artificial Intelligence Models MedEdge MEA

Chalfont St Giles, UK: GE HealthCare, Vanderbilt University Medical Center (VUMC), and the University Medicine Essen (UME), Germany, will present findings at the Society...

Read More
Menu
Categories
How does it work